Table 5.

Multivariable regression analysis of risk factors for new ischemic stroke during follow-up.

Factor	OR	95% CI	P value
Age ≥ (60 years)	1.04	0.77–1.62	0.235
Antihypertensives for hypertension	0.94	0.88–1.21	0.362
Persistence of antihypertensives	0.81	0.66–0.94	<0.001
Persistence of hypoglycemic	0.92	0.76–0.97	0.029
Lipid lowering therapy for dyslipidemia	0.95	0.93–1.19	0.422
Persistence of lipid lowering therapy	0.90	0.82–0.95	0.029
History of stroke	2.23	1.37–5.18	<0.001
Persistence of antithrombotics for stroke	0.69	0.64–0.89	<0.001
Total persistence for antihypertensives, hypoglycemics, lipid lowering medications and antithrombotics	0.68	0.62–0.87	<0.001

OR, odds ratio; CI, confidence interval.